The Federal Circuit has ruled that a settlement agreement between an inventor and Analog Devices also covers Analog’s customers, including electronic game maker Nintendo of America.
Generic drug maker Andrx Corp. has relinquished its right to a 180-day period of marketing exclusivity for the 150mg strength of GlaxoSmithKline’s smoking cessation drug Zyban, under a deal in which Andrx will share its profits on the drug with Israeli drug maker Teva.
The U.S. Court of Appeals for the Federal Circuit has reversed a lower court’s decision to invalidate drug maker Elan's patent for controlled-release naproxen.
The Supreme Court has refused to consider a trademark dispute over Idaho russet potatoes.
Indian drug maker Dr. Reddy’s has filed a manufacturing application with the U.S. Food and Drug Administration for a generic version of U.K.-Swedish pharmaceutical giant AstraZeneca’s schizophrenia drug Seroquel.
Dutch conglomerate company Akzo Nobel and its subsidiary Organon USA have agreed to pay $28 million to settle an antitrust suit brought by three generic drug makers over the company’s patent infringement suits regarding the antidepressant Remeron.
Two separate copyright lawsuits over online yacht listings could have broad implications for services that harvest information from other websites and resell their compilations to subscribers.
Generic drug maker Andrx Corp. has relinquished its right to a 180-day period of marketing exclusivity for the 150mg strength of Wellbutrin SR(R), a best-selling antidepressant from GlaxoSmithKline.
A federal judge has given both sides in the high-stakes patent suit over Eli Lilly's Zyprexa schizophrenia drug until May 12 to file all of their post-trial briefs, paving the way for a decision late this year.
Intellectual property law firm Merchant & Gould promoted Leonard Hope to a shareholder and named him to the board of directors. The firm also elected Sandra Epp Ryan and Timothy Scull to its partnership.
The Trademark Trial and Appeal Board of the U.S. Patent and Trademark Office has dismissed Miami-based Bacardi U.S.A.'s long-running claim to the Havana Club rum label.
NeoMedia has expanded its patent lawsuit over a technology that allows customers in its stores to scan CDs and DVDs to get information on the internet, such as movie previews and video art.
A federal court in Indiana will hear arguments Monday in the high-stakes battle for Eli Lilly’s top-selling drug, the $4.3-billion-a-year schizophrenia medicine Zyprexa.
Alexandria, VA-based IP boutique Oblon, Spivak has elected Philippe J.C. Signore, Ph.D. and Robert C. Mattson as new members.
Court replaces temporary restraining order with preliminary injunction to prevent Eon Labs from introducing Bupropion, the generic equivalent of GlaxoSmithKline’s antidepressant Wellbutrin.
F. Leslie Bessenger, III, Houtan K. Esfahani, Esther H. Lim, Michael A. Morin, Erik R. Puknys, and Douglas A. Rettew will assume their new positions on January 1, 2004.
Florida court enters a summary judgment of non-infringement in patent suit against SmartDisk and Fuji Photo Film U.S.A.
The U.S. District Court for the Southern District of New York again extended the restraining order to prevent Eon Labs from introducing Bupropion, the generic equivalent of GlaxoSmithKline’s antidepressant Wellbutrin.
Senate vote on spending bill with provision banning human-organism patents could be delayed until late January.
Legal battle for antidepressant blockbuster heats up as Andrx gets restraining order on ANDA approval for drug contested by GlaxoSmithKline and Eon Labs.